Cargando…
PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis
INTRODUCTION: Focal segmental glomerulosclerosis (FSGS) is characterized by proteinuria and a histologic pattern of glomerular lesions of diverse etiology that share features including glomerular scarring and podocyte foot process effacement. Roundabout guidance receptor 2 (ROBO2)/slit guidance liga...
Autores principales: | Beck, Laurence H., Berasi, Stephen P., Copley, J. Brian, Gorman, Donal, Levy, Daniel I., Lim, Chay Ngee, Henderson, Joel M., Salant, David J., Lu, Weining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207305/ https://www.ncbi.nlm.nih.gov/pubmed/34169203 http://dx.doi.org/10.1016/j.ekir.2021.03.892 |
Ejemplares similares
-
A Phase 1 first‐in‐human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF‐06730512 in healthy participants
por: Lim, Chay Ngee, et al.
Publicado: (2021) -
A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United States
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2021) -
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007) -
Pathophysiology of focal segmental glomerulosclerosis
por: Reidy, Kimberly, et al.
Publicado: (2007) -
Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016)